본문 바로가기
KERD
논문KCI 등재

단일 대학병원의 지역의약품안전센터에 보고된 소아청소년의 약물유해반응 분석

Analysis of pediatric adverse drug reactions reported to regional pharmacovigilance center of a single university hospital

남영희|정진아|이영석|최윤창|김도우
대한 소아알레르기 호흡기학회 (The Korean Academy Of Pediatric Allergy And Respiratory Disease)|2018.09|Allergy Asthma & Respiratory Disease (알레르기 천식 호흡기질환)|제6권 제5호|pp. 263-269|DOI https://doi.org/10.4168/aard.2018.6.5.263

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

ChildAntibioticsAdverse drug reactions
주제분류소아과학

초록

Purpose: Adverse drug reactions (ADRs) are a recurring problem among pediatric patients, and the incidence is increasing. However, there have been only a few studies on the clinical presentation of pediatric ADRs in Korea. This study investigated the clinical presentation of ADRs and the causative drugs in pediatric patients from a single university hospital. Methods: We retrospectively collected the data on pediatric ADRs as reported to the Regional Pharmacovigilance Center in Dong-A University Hospital between March 2013 and July 2016. We analyzed clinical presentations associated with the events. To determinate causality, we evaluated each ADR according to the Naranjo probability scale, the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) criteria and the Korean ADR algorithm. Results: A total of 365 ADR cases were reported. Sixty-eight patients (26.5%) responded to 2 or more drugs. Antibiotics (43.3%) were the most common causative drugs, of whom the third generation cephalosphorins caused most ADRs. The most common clinical presentations were gastrointestinal manifestations (36.6%). A total of 312 ADRs were reported in 257 patients based on both the Naranjo probability scale and the Korean ADR algorithm. In addition, 323 ADRs were reported in 257 patients based on the WHO-UMC criteria. Conclusion: Various drugs are related to ADRs in pediatric patients. Further efforts to improve ADR-reporting systems and to increase awareness of ADRs in pediatric patients are needed.

Abstract

Purpose: Adverse drug reactions (ADRs) are a recurring problem among pediatric patients, and the incidence is increasing. However, there have been only a few studies on the clinical presentation of pediatric ADRs in Korea. This study investigated the clinical presentation of ADRs and the causative drugs in pediatric patients from a single university hospital. Methods: We retrospectively collected the data on pediatric ADRs as reported to the Regional Pharmacovigilance Center in Dong-A University Hospital between March 2013 and July 2016. We analyzed clinical presentations associated with the events. To determinate causality, we evaluated each ADR according to the Naranjo probability scale, the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) criteria and the Korean ADR algorithm. Results: A total of 365 ADR cases were reported. Sixty-eight patients (26.5%) responded to 2 or more drugs. Antibiotics (43.3%) were the most common causative drugs, of whom the third generation cephalosphorins caused most ADRs. The most common clinical presentations were gastrointestinal manifestations (36.6%). A total of 312 ADRs were reported in 257 patients based on both the Naranjo probability scale and the Korean ADR algorithm. In addition, 323 ADRs were reported in 257 patients based on the WHO-UMC criteria. Conclusion: Various drugs are related to ADRs in pediatric patients. Further efforts to improve ADR-reporting systems and to increase awareness of ADRs in pediatric patients are needed.

참고문헌 (26)

  1. "International drug monitoring: the role of national centres. Report of a WHO meeting", World Health Organ Tech Rep Ser, 498, pp.1~25 (1972)
  2. "Pharmacovigilance terminology"[URL]
  3. Lazarou J, "Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies", JAMA, 279, pp.1200~1205 (1998)[DOI]
  4. Moore TJ, "Serious adverse drug events reported to the Food and Drug Administration, 1998-2005", Arch Intern Med, 167, pp.1752~1759 (2007)[DOI]
  5. "Program and Abstract, the 65th Annual Fall Meeting of the Korean Pediatric Society", 2015, 65~, pp.The Korean Pediatric Society
  6. Roughead E, "Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners", Pharmacoepidemiol Drug Saf, 16, pp.797~803 (2007)[DOI]
  7. Turner S, "Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study", Acta Paediatr, 88, pp.965~968 (1999)[DOI]
  8. Choonara I, "Unlicensed and off-label drug use in children: implications for safety", Drug Saf, 25, pp.1~5 (2002)[DOI]
  9. 김명현, "단일 3차 의료기관에서 수집한 약물 유해반응의 양상 분석", 천식 및 알레르기, 28(1), pp.35~39 (2008), 대한천식알레르기학회
  10. 김민강, "단일기관에서 전산을 통해 수집된 자발적 약물유해반응 보고사례들의 분석", 대한내과학회지, 77(5), pp.601~609 (2009), 대한내과학회
  11. 김정은, "노인 입원환자에서 발생한 약물유해반응의 특성", 천식 및 알레르기, 30(3), pp.216~221 (2010), 대한천식알레르기학회
  12. 최정희, "단일 3차 의료기관에서 약물 이상 반응의 빈도", 대한내과학회지, 67(3), pp.290~296 (2004), 대한내과학회
  13. 박근미, "단일기관에서 전산을 통해 수집된 자발적 소아 약물유해반응 보고사례의 분석", Allergy Asthma & Respiratory Disease, 4(5), pp.354~359 (2016), 대한 소아알레르기 호흡기학회[DOI]
  14. Adverse Drug Reaction Assessment Report, , Korea Institute of Drug Safety & Risk Management, 61~ (2013)
  15. Naranjo CA, "A method for estimating the probability of adverse drug reactions", Clin Pharmacol Ther, 30, pp.239~245 (1981)[DOI]
  16. Edwards IR, "Adverse drug reactions: definitions, diagnosis, and management", Lancet, 356, pp.1255~1259 (2000)[DOI]
  17. 홍경섭, "약물이상반응의 인과성 평가를 위한 한국형 알고리즘의 개발", Translational and Clinical Pharmacology, 10(2), pp.129~142 (2002), 대한임상약리학회
  18. 류성윤, "단일 대학병원 약물유해반응의 보고 및 임상양상", 천식 및 알레르기, 31(3), pp.184~191 (2011), 대한천식알레르기학회
  19. Kim HM, "Analysis of adverse events reporting patterns and signal detection for pediatric patients in the Korean spontaneous reporting data", Korean Soc Pharmacoepidemiol Risk Manage, 5, pp.40~45 (2012)
  20. Ferrajolo C, "Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001-2012", Expert Opin Drug Saf, 13(Suppl 1), pp.S9~S20 (2014)[DOI]
  21. Chung EH, "Vaccine allergies", Clin Exp Vaccine Res, 3, pp.50~57 (2014)[DOI]
  22. Hawcutt DB, "Reported paediatric adverse drug reactions in the UK 2000-2009", Br J Clin Pharmacol, 73, pp.437~446 (2012)[DOI]
  23. Ahn BS, "Development of a new adverse drug reaction monitoring system in general hospital and evaluation of its outcome", J Korean Soc Med Inform, 5, pp.149~158 (1999)
  24. 유기연, "식품의약품안전청 약물유해반응 보고자료 분석", 한국임상약학회지, 21(2), pp.138~144 (2011), 한국임상약학회
  25. Sacilotto K, "Adverse drug effect notifications by nurses and comparison with cases reported by physicians", Therapie, 50, pp.455~458 (1995)
  26. 송명균, "약물유해반응의 인과관계 판정을 위한 Naranjo와 WHO-UMC 지표의 비교", 대한내과학회지, 74(2), pp.181~187 (2008), 대한내과학회

관련 논문AI추천

단일기관에서 전산을 통해 수집된 자발적 소아 약물유해반응 보고사례의 분석이 은, 김영호, 김재연, 김태범, 박근미, 박주현, 유진호, 윤지선, 정주원, 조현주, 한혜원, 홍수종대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2016 · 제4권 제5호소아 약물유해반응 보고 사례 분석김정태, 유기연, 정지현한국병원약사회 · 병원약사회지2013 · 제30권 제2호원내 소아 환자에서 보고된 약물 부작용 사례 분석고종희, 금민정, 김성은, 김수현, 박은혜, 석현주한국병원약사회 · 병원약사회지2011 · 제28권 제3호약물이상반응 감시 현황: 단일기관 10년 자료 분석강동윤, 강혜련, 김현화, 문미라, 박가윤, 박수빈, 이주연, 조상헌, 조윤숙대한내과학회 · 대한내과학회지2021 · 제96권 제4호단일 대학병원 약물유해반응의 보고 및 임상양상고영일, 김민석, 김하나, 류성윤, 류시현, 박승환, 신희영, 천승우대한천식알레르기학회 · 천식 및 알레르기2011 · 제31권 제3호단일기관 소아청소년 입원환자에서의 허가 외 약물 사용 현황 분석김찬영, 박근미, 신예지, 정주원, 한혜원한국병원약사회 · 병원약사회지2021 · 제38권 제3호

이 간행물의 다른 논문 (7건)

조영제 과민반응 환자에서 피부시험이 안전한 조영제 선별에 도움이 되는가?김태범pp. 235-236소아의 혈청 특이 IgE 측정 검사를 위한 적절한 항원 선택양현종, 윤종서, 이용주, 한만용, 김진택, 김창근pp. 237-240기도 내 이물질 소아에서 단순 흉부방사선사진과 가슴 전산화단층촬영윤종서, 박유미, 김현희, 이혜진, 김진택, 김경훈, 임수아, 양은애, 이의경, 김환수, 전윤홍pp. 241-247Polymerase chain reaction 양성 소아 마이코플라스마 폐렴에서 혈청 IgM enzyme-linked immunosorbent assays의 진단적 가치김경훈, 양은애, 김환수, 전윤홍, 윤종서, 이혜진, 이윤태, 김현희, 김진택pp. 248-254분석 방법 변화에 따른 음성 대조군과 호흡기 검체 간 미생물 구성 차이 비교이상표, 김효정, 강신명, 이상민, 정성원, 강성윤pp. 255-262
원문 보기